TITLE

BROMELAIN: AN ANTI-INFLAMMATORY AGENT

AUTHOR(S)
Seligman, Bert
PUB. DATE
November 1962
SOURCE
Angiology;Nov1962, Vol. 13 Issue 11, p508
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the pharmacological characteristics of bromelain. Functions of bromelain; Arterial diseases that can be manage with bromelain; Indications of bromelain.
ACCESSION #
16369288

 

Related Articles

  • Oral Bepotastine.  // Drugs;2010, Vol. 70 Issue 12, p1579 

    No abstract available.

  • Dexlansoprazole Modified Release.  // Drugs;2010, Vol. 70 Issue 12, p1593 

    No abstract available.

  • Age-Related Changes in Pharmacokinetics. Shi, Shaojun; Klotz, Ulrich // Current Drug Metabolism;Sep2011, Vol. 12 Issue 7, p601 

    Ageing is characterized by a progressive decline in the functional reserve of multiple organs and systems, which can influence drug disposition. In addition, comorbidity and polypharmacy are highly prevalent in the elderly. As ageing is associated with some reduction in first-pass metabolism,...

  • Fluvoxamine significantly alters tizanidine pharmacokinetics.  // Reactions Weekly;6/19/2004, Issue 1006, p4 

    Reports on a study conducted by researchers from Finland on the effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of tizanidine. Dosage of fluvoxamine administered to the study's participants; Increase in the pharmacodynamic responses to tizanidine following fluvoxamine...

  • Practical Review of Pharmacology Concepts. Janda, Sue M.; Fagan, Nancy L. // Urologic Nursing;Jan/Feb2010, Vol. 30 Issue 1, p15 

    The article offers a practical review of pharmacokinetic and pharmacodynamic concepts. The four phases of pharmacokinetics, namely, the absorption, distribution, metabolism and excretion, are explained. It describes pharmacokinetics, which refers to how drugs change the body. Also mentioned is...

  • Oral Colchicine (Colcrys).  // Drugs;2010, Vol. 70 Issue 12, p1603 

    No abstract available.

  • Simulation and prediction of in vivo drug metabolism in human populations from in vitro data. Rostami-Hodjegan, Amin; Tucker, Geoffrey T. // Nature Reviews Drug Discovery;Feb2007, Vol. 6 Issue 2, p140 

    The perceived failure of new drug development has been blamed on deficiencies in in vivo studies of drug efficacy and safety. Prior simulation of the potential exposure of different individuals to a given dose might help to improve the design of such studies. This should also help researchers to...

  • Oral Prostacyclins/Analogs for PAH: Current Status and Challenges. Rubin, Lewis // Current Medical Literature: Pulmonary Hypertension;2012 Supplement, p7 

    The article discusses the current status and challenges of prostacyclin therapy to pulmonary hypertension (PH) patients. It claims that different studies have been conducted whose goal is to explore the effectiveness of three main prostanoids including treprostinil, beraprost and selexipag. It...

  • Dose adjustment of drugs with high hepatic extraction are required in patients with severe liver disease.  // Drugs & Therapy Perspectives;May2006, Vol. 22 Issue 5, p23 

    Severe liver disease may result in dose-related or idiopathic increases in drug exposure and adverse effects, especially with drugs with a high hepatic extraction and narrow therapeutic index. The dose of drugs may be adjusted according to their degree of hepatic extraction and protein binding....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics